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Accumulation of naive-phenotype CD8+ T cells and enhanced spleen size 





































Reduced activation of CD8+ T cells during LCMV infection of 2B4-KO 

















Reduced magnitude of the LCMV-specific CD8+ T cell response dur-
ing persistent LCMV clone 13 infection of 2B4-KO mice. (A) Repre-
sentative viral peptide–induced IFN-γ expression by splenic T cells 
9 days after infection with 2 × 106 PFU LCMV clone 13 i.v. Numbers 
represent mean ± SD of the percentage of IFN-γ+ CD4+ or CD8+ T 
cells from all the similarly treated mice in the experiment (n = 4). (B) 
Proportions of LCMV GP33-41–stimulated IFN-γ+ splenic or peripheral 
blood CD8+ T cells are plotted as mean ± SEM (n = 3–8/group) across 
a range of time points during persistent LCMV clone 13 infection. (C) 
Total numbers (mean ± SEM) of GP33-41– and NP396-404–specific IFN-γ+ 
splenic CD8+ T cells in WT and 2B4-KO mice (n = 10–15/group) at day 
6 of infection. (D) Representative CD8+ T cell IFN-γ expression (mean 
± SD) in the blood (n = 4) at day 35 of LCMV clone 13 infection. (E) 
IFN-γ responses (mean ± SD) by GP33-41–specific CD8+ T cells in the 
iLNs and lungs of WT and 2B4-KO mice (n = 3–4/group) at days 6 and 
21 of LCMV clone 13 infection. (F and G) Frequencies (mean ± SEM) 
of day 6 (n = 6–11/group) LCMV NP396/Db (F) and day 8 (n = 8/group) 
GP33/Db (G) tetramer-binding CD8+ T cells in the spleen. *P < 0.05, 
**P < 0.01 (2-tailed unpaired Student’s t test). Data are from 1 of 3–4 
experiments with similar results.
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Reduced LCMV-specific CTL activity and increased viral burden in the absence of 2B4 in vivo. Splenocytes from uninfected WT donor mice were 
loaded with LCMV peptides (GP33-41 or NP396-404) or no peptide, labeled with various concentrations (2.5, 1, or 0.4 μM) of CFSE, mixed at equal 
ratios, and injected (2 × 106 total targets) i.v. into LCMV clone 13–infected recipients (day 4 p.i.) or uninfected WT or 2B4-KO control mice. After 
20 hours, spleens were harvested from WT and 2B4-KO recipient mice and analyzed for recovery of each CFSE-labeled target population. (A) 
Representative histograms demonstrate recovery of NP396-404–labeled (low CFSE), GP33-41–labeled (middle CFSE), and unlabeled (high CFSE) 
peaks. Numbers represent the percent specific lysis of LCMV peptide–coated targets relative to unlabeled control targets within each experi-
mental mouse. Specific lysis of LCMV peptide–coated targets within individual mice is plotted on the right. Each circle represents an individual 
mouse, and horizontal lines denote the mean. (B) At various time points after infection, organs were harvested from LCMV clone 13–infected 
mice, and infectious virus was quantified by standard plaque assay. Titers are plotted as the arithmetic mean ± SD of the log10 of PFU per organ 
(n = 3–10 mice/group). The y axis lower limit is set at the limit of detection for the liver (log10 2.0) and spleen (log10 1.0) assays. *P < 0.05, **P < 0.01 
(2-tailed unpaired Student’s t test). Data are from 1 of 3 experiments with similar results.
research article
























Elevated frequency of naive-phenotype (CD44lo) CD8+ T cells in LCMV clone 13–infected 2B4-KO mice. (A) Representative histograms demon-
strate the expression of various activation receptors by CD8+ and CD4+ T cells at day 8 of LCMV clone 13 infection in WT (shaded histograms) 
and 2B4-KO (solid line) mice. The y axis represents percent of maximum. Numbers are mean proportion ± SD of WT (non-bold type) and 2B4-KO 
(bold type) T cells (n = 4 mice/group) falling with the gated expression range of each activation marker. (B) The mean ± SEM total number of 
naive (CD44lo) or activated (CD44hi) phenotype CD8+ T cells in the spleen of uninfected (n = 4/group) or day 8 clone 13–infected (n = 8/group) 
is plotted. (C) Histograms demonstrating reduced expression of CD44 by CD8+ T cells in the iLNs and lungs of 2B4-KO mice (n = 3–4/group, 
mean ± SD) at days 8 and 14 p.i. (D) Representative plots demonstrating a reduced frequency of CD44hi activated phenotype CD8+ T cells in 
2B4-KO mice (n = 4/group, mean ± SD) at later time points of LCMV clone 13 infection. *P < 0.05, **P < 0.01 (2-tailed unpaired Student’s t test). 
Data are from 1 of 3 experiments with similar results.
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Splenomegaly during persistent 
LCMV clone 13 infection of 2B4-KO 
mice. At various time points after 
LCMV clone 13 infection, spleens 
were photographed and the total 
number of splenic leukocytes 
determined after red blood cell 
lysis. Mean splenocyte counts 
(±SEM) are plotted for WT and KO 
mice (n = 4–10/group) throughout 
the course of infection. *P < 0.05, 
**P < 0.01 (2-tailed unpaired Stu-
dent’s t test).
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Reduced activation of CD8+ T cells in 2B4-KO mice is caused by NK cells rather than defects in CD8-intrinsic 2B4 signaling. WT congenic 
(Thy1.1+) splenocytes (3 × 107) were i.v. transferred into WT and 2B4-KO mice (Thy1.2+ host) 1 day before infection with LCMV clone 13. Two 
days before transfer, some groups of recipient mice received 25 μg of either isotype (IgG2a) control or anti-NK1.1 mAb. (A) Representative 
gating of Thy1.1+ (donor, red) and Thy1.1– (host, blue) CD8+ T cells in WT and 2B4-KO recipient mice at day 6 p.i. is shown at left. Expression 
of CD44 on donor (red histograms) and host (blue histograms) CD8+ T cells is shown, with numbers representing mean ± SD of CD44hi CD8+ T 
cells. (B) CFSE dilution (mean ± SD CFSElo) is shown for Thy1.1+ (donor) CD8+ T cells in the spleen, iLN, and blood of recipient mice. *P < 0.05, 
**P < 0.01 (2-tailed unpaired Student’s t test). Data are from 1 of 3 experiments with similar results.
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Figure 6
Depletion of NK cells restores LCMV-specific CD8+ T cell responses and viral clearance in 2B4-KO mice to WT levels. (A–D) One day prior 
to infection, WT and 2B4-KO mice (n = 4–8/group) were treated with 25 μg isotype (IgG2a) or anti-NK1.1 mAb i.p. (A) Splenic leukocytes 
(mean ± SD) were enumerated on day 9 p.i. in WT and 2B4-KO mice. (B) Mean proportion (±SD) of IFN-γ+ CD8+ T cells in spleen after GP33-41 
stimulation. (C) Viral titers at day 90 p.i. (n = 7–8/group) are displayed as log10 PFU/liver. The horizontal line represents the limit of detection 
for the plaque assay (log10 2.0). (D) Mean (±SD) fraction of DP thymocytes within thymus of uninfected or day 9 p.i. WT and 2B4-KO mice. 
(E) A single injection of anti-NK1.1 mAb was administered at various time points (day 0 to day 4) relative to the time of infection with LCMV 
clone 13. Representative spleen size (photo) and CD44 expression (y axis represents percent of maximum) on splenic CD8+ T cells was 
determined at day 10 of infection (n = 2 mice/group, mean ± SD). *P < 0.05, **P < 0.01 (2-tailed unpaired Student’s t test). Data are from 
1 of 3 experiments with similar results.
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NK cells mediate early loss of highly activated CD8+ T cells in 2B4-KO mice in a perforin-dependent manner. (A) At day 4 of LCMV clone 13 infec-
tion, splenocytes (n = 4/group) were gated on Thy 1.2-expressing cells, and the proportion of CD8α+ T cells expressing CD11c was determined. 
The Thy1.2+CD8α+CD11c+ events were uniformly CD8β+, CD3ε-expressing, and CD44hi. Right: Proportion of CD44hiCD43(1B11)+ events among 
gated CD8αβ+ T cells. Numbers represent mean (±SD) proportion of gated events. Total numbers (mean ± SEM) of Thy1.2+CD11c+CD8α+ cells 
were determined in the spleens (B) as well as iLNs (C) of isotype-treated or anti-NK1.1–treated WT and 2B4-KO mice (n = 5/group), as well as 
in the spleens (D) of similarly treated Prf1-KO and 2B4/Prf1-KO (n = 3–4/group) mice. **P < 0.01 (2-tailed unpaired Student’s t test). Data are 
from 1 of 3 experiments with similar results.
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NK cells mediate specific lysis of activated CD8+ T cells in the absence of 2B4 in vitro and in vivo. (A) WT (black bars) or 2B4-KO (white bars) 
LAK cell killing (mean ± SD) of WT CD8+ T cell targets, activated in vitro with various doses of ConA. (B) Specific lysis (mean ± SD) of WT or 
CD48-KO ConA-activated CD8+ T cells by WT (left) or by Prf1-KO (right) LAK cells is shown at various effector to target (E/T) ratios. (C and D) A 
modified in vivo cytotoxicity assay was done by injecting CFSE-labeled splenocytes (3 × 107) from LCMV-infected (day 4 p.i.) congenic (Ly5.1+) 
WT mice into uninfected or LCMV-infected (day 4 p.i.) WT and 2B4-KO mice (Ly5.2+, n = 5–6/group), some of which were depleted of NK cells 
1 day prior to infection. Five hours after transfer, the proportion of activated (CD44hiCD43[1B11]+) donor (Ly5.1+CFSE+) cells was determined 
in each mouse. (C) Representative CD44 and CD43(1B11) expression by donor Ly5.1+CFSE+ CD8+ T cells. Numbers are the percentage of 
donor (Ly5.1+CFSE+) CD8+ T cells that are CD44hiCD43(1B11)+ for the representative sample shown. (D) Top graphs depict the percentage of 
activated CD44hiCD43(1B11)+ donor (Ly5.1+CFSE+) CD8+ T cells in isotype- (left) or anti-NK1.1–treated (right) WT and 2B4-KO mice. Lower left 
plot demonstrates the proportion of naive phenotype (CD44loCD43[1B11]–) donor (Ly5.1+CFSE+) CD8+ T cells in isotype-treated WT and 2B4-KO 
mice. Lower right plot depicts the percentage of activated CD44hiCD43(1B11)+ donor (Ly5.1+CFSE+) CD8+ T cells in Prf1-KO and 2B4/Prf1-KO 
mice. Results are presented as mean ± SD. **P < 0.01 (2-tailed unpaired Student’s t test). Data are from 1 of 3 similar experiments.
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